Oxford Target Therapeutics Limited (13886983) is a private limited with share capital incorporated on 02/02/2022 (4 years old) and registered in oxford, OX30BP. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Termination Director Company With Name Termination Date
Category:Officers
Date:05-11-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:05-11-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:19-07-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:20-05-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:20-05-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:17-05-2024
Change Person Director Company With Change Date
Category:Officers
Date:17-05-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:17-05-2024
Change Person Director Company With Change Date
Category:Officers
Date:17-05-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:17-05-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:02-11-2023
Change Account Reference Date Company Previous Extended
Category:Accounts
Date:19-09-2023
Change Person Director Company With Change Date
Category:Officers
Date:19-05-2023
Change Person Director Company With Change Date
Category:Officers
Date:19-05-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:19-05-2023
Resolution
Category:Resolution
Date:15-09-2022
Capital Alter Shares Subdivision
Category:Capital
Date:14-09-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:10-05-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:06-05-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:06-05-2022
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-05-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:06-05-2022
Incorporation Company
Category:Incorporation
Date:02-02-2022
Innovate Grants
1
This company received a grant of £296532.0 for Oxford Target Therapeutics: Innovative Therapy To Halt Proliferation Of High Mortality Cancer. The project started on 01/09/2022 and ended on 31/03/2024.